MARKET

BJDX

BJDX

Bluejay Diagnostics Inc
NASDAQ
3.250
-0.060
-1.81%
Opening 09:53 06/26 EDT
OPEN
3.230
PREV CLOSE
3.310
HIGH
3.260
LOW
3.185
VOLUME
12.07K
TURNOVER
--
52 WEEK HIGH
16.68
52 WEEK LOW
1.623
MARKET CAP
3.36M
P/E (TTM)
-0.0602
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BJDX last week (0615-0619)?
Weekly Report · 4d ago
Bluejay Diagnostics files to sell 11.22M shares of common stock for holders
TipRanks · 06/17 21:25
Weekly Report: what happened at BJDX last week (0608-0612)?
Weekly Report · 06/15 10:02
Bluejay Diagnostics Shareholders Approve Stock Plan and Flexibility
TipRanks · 06/09 22:47
Bluejay Diagnostics shareholders approve 600,000-share increase to 2021 stock plan reserve
PUBT · 06/09 21:27
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 06/09 12:05
Bluejay Diagnostics Completes Private Placement to Extend Runway
TipRanks · 06/08 22:52
Weekly Report: what happened at BJDX last week (0601-0605)?
Weekly Report · 06/08 09:59
More
About BJDX
Bluejay Diagnostics, Inc. is a medical diagnostics company focused on improving patient outcomes in critical care settings. It develops rapid tests using whole blood on its Symphony technology platform (Symphony), which consists of an analyzer and single-use protein detection cartridges that have the function of automatic stepwise feeding of reagent. The Symphony device is designed to produce laboratory-quality results in 20 minutes in critical care settings, including Intensive Care Units (ICUs) and Emergency Rooms (ERs). Its product candidate, the Symphony IL-6 test, is an immunoassay for the measurement of interleukin-6 (IL-6) to be used for the monitoring of disease progression in critical care settings. It is focused on pursuing the Symphony IL-6 test in the context of sepsis. IL-6 is a clinically established inflammatory biomarker, and is considered a 'first-responder', for the assessment of severity of infection and inflammation across many disease indications, including sepsis.

Webull offers Bluejay Diagnostics Inc stock information, including NASDAQ: BJDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BJDX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BJDX stock methods without spending real money on the virtual paper trading platform.